Table of Contents Author Guidelines Submit a Manuscript
International Journal of Cell Biology
Volume 2013, Article ID 435981, 13 pages
http://dx.doi.org/10.1155/2013/435981
Review Article

Trafficked Proteins—Druggable in Plasmodium falciparum?

1Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Science, University of São Paulo, Avenida Prof. Lineu Prestes 1374, 05508-000 São Paulo, SP, Brazil
2Laboratory of Genetics and Molecular Cardiology, Heart Institute InCor, Avenida Dr. Eneas de Carvalho Aguiar 44, 05403-000 São Paulo, SP, Brazil

Received 20 January 2013; Accepted 12 March 2013

Academic Editor: Haruki Hasegawa

Copyright © 2013 Jasmin Lindner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization (WHO), World Malaria Report 2011, WHO, Geneva, Switzerland, 2012.
  2. J. Sachs and P. Malaney, “The economic and social burden of malaria,” Nature, vol. 415, no. 6872, pp. 680–685, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Hecht and G. B. Fogel, “Modeling the evolution of drug resistance in malaria,” Journal of Computer-Aided Molecular Design, vol. 26, no. 12, pp. 1343–1353, 2012. View at Publisher · View at Google Scholar
  4. C. J. Murray, L. C. Rosenfeld, S. S. Lim et al., “Global malaria mortality between 1980 and 2010: a systematic analysis,” The Lancet, vol. 379, no. 9814, pp. 413–431, 2012. View at Publisher · View at Google Scholar
  5. R. F. Schumacher and E. Spinelli, “Malaria in children,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 4, no. 1, Article ID e2012073, 2012. View at Publisher · View at Google Scholar
  6. F. Nosten, S. J. Rogerson, J. G. Beeson, R. McGready, T. K. Mutabingwa, and B. Brabin, “Malaria in pregnancy and the endemicity spectrum: what can we learn?” Trends in Parasitology, vol. 20, no. 9, pp. 425–432, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. T. N. C. Ramya, K. Karmodiya, A. Surolia, and N. Surolia, “15-deoxyspergualin primarily targets the trafficking of apicoplast proteins in Plasmodium falciparum,” Journal of Biological Chemistry, vol. 282, no. 9, pp. 6388–6397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. T. N. C. Ramya, N. Surolia, and A. Surolia, “15-deoxyspergualin modulates Plasmodium falciparum heat shock protein function,” Biochemical and Biophysical Research Communications, vol. 348, no. 2, pp. 585–592, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Banerjee, R. R. Singh, S. Gupta, A. Surolia, and N. Surolia, “15-deoxyspergualin hinders physical interaction between basic residues of transit peptide in PfENR and Hsp70-1,” IUBMB Life, vol. 64, no. 1, pp. 99–107, 2012. View at Publisher · View at Google Scholar
  10. S. Briolant, N. Wurtz, A. Zettor, C. Rogier, and B. Pradines, “Susceptibility of Plasmodium falciparum isolates to doxycycline is associated with pftetQ sequence polymorphisms and pftetQ and pfmdt copy numbers,” Journal of Infectious Diseases, vol. 201, no. 1, pp. 153–159, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C. D. Goodman, V. Su, and G. I. McFadden, “The effects of anti-bacterials on the malaria parasite Plasmodium falciparum,” Molecular and Biochemical Parasitology, vol. 152, no. 2, pp. 181–191, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Jomaa, J. Wiesner, S. Sanderbrand et al., “Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs,” Science, vol. 285, no. 5433, pp. 1573–1576, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Y. Botte, F. Dubar, G. I. McFadden, E. Maréchal, and C. Biot, “Plasmodium falciparum apicoplast drugs: targets or off-targets?” Chemical Reviews, vol. 112, no. 3, pp. 1269–1283, 2012. View at Publisher · View at Google Scholar
  14. M. Okuhara, Y. Kuroda, and T. Goto, “Studies on new phosphonic acid antibiotics. I. FR-900098, isolation and characterization,” Journal of Antibiotics, vol. 33, no. 1, pp. 13–17, 1980. View at Google Scholar · View at Scopus
  15. C. S. Gavigan, J. P. Dalton, and A. Bell, “The role of aminopeptidases in haemoglobin degradation in Plasmodium falciparum-infected erythrocytes,” Molecular and Biochemical Parasitology, vol. 117, no. 1, pp. 37–48, 2001. View at Google Scholar · View at Scopus
  16. M. F. Nankya-Kitaka, G. P. Curley, C. S. Gavigan, A. Bell, and J. P. Dalton, “Plasmodium chabaudi chabaudi and P. falciparum: inhibition of aminopeptidase anti parasite growth by bestatin and nitrobestatin,” Parasitology Research, vol. 84, no. 7, pp. 552–558, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. T. S. Skinner-Adams, J. Lowther, F. Teuscher et al., “Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds,” Journal of Medicinal Chemistry, vol. 50, no. 24, pp. 6024–6031, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. McGowan, C. J. Porter, J. Lowther et al., “Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 8, pp. 2537–2542, 2009. View at Publisher · View at Google Scholar
  19. J. Grembecka, A. Mucha, T. Cierpicki, and P. Kafarski, “The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity,” Journal of Medicinal Chemistry, vol. 46, no. 13, pp. 2641–2655, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. S. E. Francis, L. Y. Gluzman, A. Oksman et al., “Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase,” EMBO Journal, vol. 13, no. 2, pp. 306–317, 1994. View at Google Scholar · View at Scopus
  21. E. Bailly, R. Jambou, J. Savel, and G. Jaureguiberry, “Plasmodium falciparum: differential sensitivity in vitro to E-64 (cysteine protease inhibitor) and Pepstatin A (aspartyl protease inhibitor),” Journal of Protozoology, vol. 39, no. 5, pp. 593–599, 1992. View at Google Scholar · View at Scopus
  22. K. Hidaka, T. Kimura, A. J. Ruben et al., “Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin,” Bioorganic & Medicinal Chemistry, vol. 16, no. 23, pp. 10049–10060, 2008. View at Publisher · View at Google Scholar
  23. A. Nezami, T. Kimura, K. Hidaka et al., “High-affinity inhibition of a family of Plasmodium falciparum proteases by a designed adaptive inhibitor,” Biochemistry, vol. 42, no. 28, pp. 8459–8464, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Miura, K. Hidaka, T. Uemura et al., “Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution,” Bioorganic and Medicinal Chemistry Letters, vol. 20, no. 16, pp. 4836–4839, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. J. Meyers and D. E. Goldberg, “Recent advances in plasmepsin medicinal chemistry and implications for future antimalarial drug discovery efforts,” Current Topics in Medicinal Chemistry, vol. 12, no. 5, pp. 445–455, 2012. View at Publisher · View at Google Scholar
  26. J. M. M. Ndong, C. Atteke, A. Aubouy, M. Bakary, J. Lébibi, and P. Deloron, “In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum,” Tropical Medicine and International Health, vol. 8, no. 1, pp. 25–29, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. A. B. S. Sidhu, A. C. Uhlemann, S. G. Valderramos, J. C. Valderramos, S. Krishna, and D. A. Fidock, “Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin,” Journal of Infectious Diseases, vol. 194, no. 4, pp. 528–535, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. A. C. Uhlemann and S. Krishna, “Antimalarial multi-drug resistance in Asia: mechanisms and assessment,” Current Topics in Microbiology and Immunology, vol. 295, pp. 39–53, 2005. View at Google Scholar · View at Scopus
  29. T. Mita and K. Tanabe, “Evolution of Plasmodium falciparum drug resistance: implications for the development and containment of artemisinin resistance,” Japanese Journal of Infectious Diseases, vol. 65, no. 6, pp. 465–475, 2012. View at Google Scholar
  30. K. Mugittu, M. Ndejembi, A. Malisa et al., “Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance,” American Journal of Tropical Medicine and Hygiene, vol. 71, no. 6, pp. 696–702, 2004. View at Google Scholar · View at Scopus
  31. F. Marks, V. von Kalckreuth, R. Kobbe et al., “Parasitological rebound effect and emergence of pyrimethamine resistance in Plasmodium falciparum after single-dose sulfadoxine-pyrimethamine,” Journal of Infectious Diseases, vol. 192, no. 11, pp. 1962–1965, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. Q. L. Fivelman, G. A. Butcher, I. S. Adagu, D. C. Warhurst, and G. Pasvol, “Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria,” Malaria Journal, vol. 1, article no. 1, pp. 1–4, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. N. J. White, “Qinghaosu (artemisinin): the price of success,” Science, vol. 320, no. 5874, pp. 330–334, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Witkowski, N. Khim, P. Chim et al., “Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia,” Antimicrobial Agents and Chemotherapy. In press.
  35. J. H. Ch'ng, K. Liew, A. S. Goh, E. Sidhartha, and K. S. Tan, “Drug-induced permeabilization of parasite's digestive vacuole is a key trigger of programmed cell death in Plasmodium falciparum,” Cell Death & Disease, vol. 2, article e216, 2011. View at Google Scholar
  36. A. M. Dondorp, F. Nosten, P. Yi et al., “Artemisinin resistance in Plasmodium falciparum malaria,” The New England Journal of Medicine, vol. 361, no. 5, pp. 455–467, 2009. View at Publisher · View at Google Scholar
  37. P. J. Rosenthal, J. H. McKerrow, M. Aikawa, H. Nagasawa, and J. H. Leech, “A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum,” Journal of Clinical Investigation, vol. 82, no. 5, pp. 1560–1566, 1988. View at Google Scholar · View at Scopus
  38. A. G. Maier, M. Rug, M. T. O'Neill et al., “Exported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytes,” Cell, vol. 134, no. 1, pp. 48–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Hanssen, P. J. McMillan, and L. Tilley, “Cellular architecture of Plasmodium falciparum-infected erythrocytes,” International Journal for Parasitology, vol. 40, no. 10, pp. 1127–1135, 2010. View at Publisher · View at Google Scholar
  40. S. Köhler, C. F. Delwiche, P. W. Denny et al., “A plastid of probable green algal origin in Apicomplexan parasites,” Science, vol. 275, no. 5305, pp. 1485–1489, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. R. J. M. I. Wilson, P. W. Denny, P. R. Preiser et al., “Complete gene map of the plastid-like DNA of the malaria parasite Plasmodium falciparum,” Journal of Molecular Biology, vol. 261, no. 2, pp. 155–172, 1996. View at Publisher · View at Google Scholar · View at Scopus
  42. B. J. Foth, S. A. Ralph, C. J. Tonkin et al., “Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum,” Science, vol. 299, no. 5607, pp. 705–708, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. J. M. Carlton, S. V. Angiuoli, B. B. Suh et al., “Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii,” Nature, vol. 419, no. 6906, pp. 512–519, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. R. F. Waller, P. J. Keeling, R. G. K. Donald et al., “Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 21, pp. 12352–12357, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Blobel, “Intracellular protein topogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 77, no. 3, pp. 1496–1500, 1980. View at Google Scholar · View at Scopus
  46. G. von Heijne, “How signal sequences maintain cleavage specificity,” Journal of Molecular Biology, vol. 173, no. 2, pp. 243–251, 1984. View at Google Scholar · View at Scopus
  47. M. Spiess, “Heads or tails—what determines the orientation of proteins in the membrane,” FEBS Letters, vol. 369, no. 1, pp. 76–79, 1995. View at Publisher · View at Google Scholar · View at Scopus
  48. S. I. Bannykh, T. Rowe, and W. E. Balch, “The organization of endoplasmic reticulum export complexes,” Journal of Cell Biology, vol. 135, no. 1, pp. 19–35, 1996. View at Publisher · View at Google Scholar · View at Scopus
  49. R. F. Waller, M. B. Reed, A. F. Cowman, and G. I. McFadden, “Protein trafficking to the plastid of Plasmodium falciparum is via the secretory pathway,” EMBO Journal, vol. 19, no. 8, pp. 1794–1802, 2000. View at Google Scholar · View at Scopus
  50. F. Ehlgen, J. S. Pham, T. de Koning-Ward, A. F. Cowman, and S. A. Ralph, “Investigation of the Plasmodium falciparum food vacuole through inducible expression of the chloroquine resistance transporter (PfCRT),” PLoS One, vol. 7, no. 6, Article ID e38781, 2012. View at Google Scholar
  51. F. R. Albano, A. Berman, N. Greca La et al., “A homologue of Sar1p localises to a novel trafficking pathway in malaria-infected erythrocytes,” European Journal of Cell Biology, vol. 78, no. 7, pp. 453–462, 1999. View at Google Scholar · View at Scopus
  52. A. Adisa, F. R. Albano, J. Reeder, M. Foley, and L. Tilley, “Evidence for a role for a Plasmodium falciparum homologue of Sec31p in the export of proteins to the surface of malaria parasite-infected erythrocytes,” Journal of Cell Science, vol. 114, no. 18, pp. 3377–3386, 2001. View at Google Scholar · View at Scopus
  53. A. Adisa, M. Rug, N. Klonis, M. Foley, A. F. Cowman, and L. Tilley, “The signal sequence of exported protein-1 directs the green fluorescent protein to the parasitophorous vacuole of transfected malaria parasites,” Journal of Biological Chemistry, vol. 278, no. 8, pp. 6532–6542, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. I. B. Müller, J. Knöckel, M. L. Eschbach, B. Bergmann, R. D. Walter, and C. Wrenger, “Secretion of an acid phosphatase provides a possible mechanism to acquire host nutrients by Plasmodium falciparum,” Cellular Microbiology, vol. 12, no. 5, pp. 677–691, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Klemba, I. Gluzman, and D. E. Goldberg, “A Plasmodium falciparum dipeptidyl aminopeptidase I participates in vacuolar hemoglobin degradation,” Journal of Biological Chemistry, vol. 279, no. 41, pp. 43000–43007, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. S. E. Francis, R. Banerjee, and D. E. Goldberg, “Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II,” Journal of Biological Chemistry, vol. 272, no. 23, pp. 14961–14968, 1997. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Banerjee, S. E. Francis, and D. E. Goldberg, “Food vacuole plasmepsins are processed at a conserved site by an acidic convertase activity in Plasmodium falciparum,” Molecular and Biochemical Parasitology, vol. 129, no. 2, pp. 157–165, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. M. T. McIntosh, A. Vaid, H. D. Hosgood et al., “Traffic to the malaria parasite food vacuole: a novel pathway involving a phosphatidylinositol 3-phosphate-binding protein,” Journal of Biological Chemistry, vol. 282, no. 15, pp. 11499–11508, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. P. V. N. Dasaradhi, R. Korde, J. K. Thompson et al., “Food vacuole targeting and trafficking of falcipain-2, an important cysteine protease of human malaria parasite Plasmodium falciparum,” Molecular and Biochemical Parasitology, vol. 156, no. 1, pp. 12–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Subramanian, P. S. Sijwali, and P. J. Rosenthal, “Falcipain cysteine proteases require bipartite motifs for trafficking to the Plasmodium falciparum food vacuole,” Journal of Biological Chemistry, vol. 282, no. 34, pp. 24961–24969, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. N. L. Hiller, S. Bhattacharjee, C. van Ooij et al., “A host-targeting signal in virulence proteins reveals a secretome in malarial infection,” Science, vol. 306, no. 5703, pp. 1934–1937, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Marti, R. T. Good, M. Rug, E. Knuepfer, and A. F. Cowman, “Targeting malaria virulence and remodeling proteins to the host erythrocyte,” Science, vol. 306, no. 5703, pp. 1930–1933, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. T. J. Sargeant, M. Marti, E. Caler et al., “Lineage-specific expansion of proteins exported to erythrocytes in malaria parasites,” Genome Biology, vol. 7, no. 2, article R12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. J. A. Boddey, A. N. Hodder, S. Günther et al., “An aspartyl protease directs malaria effector proteins to the host cell,” Nature, vol. 463, no. 7281, pp. 627–631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. T. F. de Koning-Ward, P. R. Gilson, J. A. Boddey et al., “A newly discovered protein export machine in malaria parasites,” Nature, vol. 459, no. 7249, pp. 945–949, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. H. E. Bullen, S. C. Charnaud, M. Kalanon et al., “Biosynthesis, localization, and macromolecular arrangement of the Plasmodium falciparum translocon of exported proteins (PTEX),” The Journal of Biological Chemistry, vol. 287, no. 11, pp. 7871–7884, 2012. View at Publisher · View at Google Scholar
  67. T. Spielmann and T. W. Gilberger, “Protein export in malaria parasites: do multiple export motifs add up to multiple export pathways?” Trends in Parasitology, vol. 26, no. 1, pp. 6–10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. R. F. Waller and G. I. McFadden, “The apicoplast: a review of the derived plastid of apicomplexan parasites,” Current Issues in Molecular Biology, vol. 7, no. 1, pp. 57–80, 2005. View at Google Scholar · View at Scopus
  69. F. Seeber, “Biogenesis of iron-sulphur clusters in amitochondriate and apicomplexan protists,” International Journal for Parasitology, vol. 32, no. 10, pp. 1207–1217, 2002. View at Publisher · View at Google Scholar · View at Scopus
  70. F. Seeber, “Biosynthetic pathways of plastid-derived organelles as potential drug targets against parasitic apicomplexa,” Current Drug Targets. Immune, Endocrine and Metabolic Disorders, vol. 3, no. 2, pp. 99–109, 2003. View at Google Scholar · View at Scopus
  71. B. Kumar, S. Chaubey, P. Shah et al., “Interaction between sulphur mobilisation proteins SufB and SufC: evidence for an iron-sulphur cluster biogenesis pathway in the apicoplast of Plasmodium falciparum,” International Journal for Parasitology, vol. 41, no. 9, pp. 991–999, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. G. G. van Dooren, S. D. Schwartzbach, T. Osafune, and G. I. McFadden, “Translocation of proteins across the multiple membranes of complex plastids,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1541, no. 1-2, pp. 34–53, 2001. View at Publisher · View at Google Scholar · View at Scopus
  73. T. S. Heard and H. Weiner, “A regional net charge and structural compensation model to explain how negatively charged amino acids can be accepted within a mitochondrial leader sequence,” Journal of Biological Chemistry, vol. 273, no. 45, pp. 29389–29393, 1998. View at Publisher · View at Google Scholar · View at Scopus
  74. L. Ni, T. S. Heard, and H. Weiner, “In vivo mitochondrial import: a comparison of leader sequence charge and structural relationships with the in vitro model resulting in evidence for co-translational import,” Journal of Biological Chemistry, vol. 274, no. 18, pp. 12685–12691, 1999. View at Publisher · View at Google Scholar · View at Scopus
  75. S. A. Ralph, B. J. Foth, N. Hall, and G. I. McFadden, “Evolutionary pressures on apicoplast transit peptides,” Molecular Biology and Evolution, vol. 21, no. 12, pp. 2183–2194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. C. J. Tonkin, D. S. Roos, and G. I. McFadden, “N-terminal positively charged amino acids, but not their exact position, are important for apicoplast transit peptide fidelity in Toxoplasma gondii,” Molecular and Biochemical Parasitology, vol. 150, no. 2, pp. 192–200, 2006. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Kalanon, C. J. Tonkin, and G. I. McFadden, “Characterization of two putative protein translocation components in the apicoplast of Plasmodium falciparum,” Eukaryotic Cell, vol. 8, no. 8, pp. 1146–1154, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Gillece, J. M. Luz, W. J. Lennarz, F. J. de La Cruz, and K. Römisch, “Export of a cysteine-free misfolded secretory protein from the endoplasmic reticulum for degradation requires interaction with protein disulfide isomerase,” Journal of Cell Biology, vol. 147, no. 7, pp. 1443–1456, 1999. View at Publisher · View at Google Scholar · View at Scopus
  79. J. Wahlman, G. N. DeMartino, W. R. Skach, N. J. Bulleid, J. L. Brodsky, and A. Johnson, “Real-time fluorescence detection of ERAD substrate retrotranslocation in a mammalian in vitro system,” Cell, vol. 129, no. 5, pp. 943–955, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. B. Tsai, C. Rodighiero, W. I. Lencer, and T. A. Rapoport, “Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin,” Cell, vol. 104, no. 6, pp. 937–948, 2001. View at Publisher · View at Google Scholar · View at Scopus
  81. E. J. H. J. Wiertz, D. Tortorella, M. Bogyo et al., “Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction,” Nature, vol. 384, no. 6608, pp. 432–438, 1996. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Knop, A. Finger, T. Braun, K. Hellmuth, and D. H. Wolf, “Der1, a novel protein specifically required for endoplasmic reticulum degradation in yeast,” EMBO Journal, vol. 15, no. 4, pp. 753–763, 1996. View at Google Scholar · View at Scopus
  83. S. Borrmann, S. Issifou, G. Esser et al., “Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria,” Journal of Infectious Diseases, vol. 190, no. 9, pp. 1534–1540, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. R. A. Ivey III and B. D. Bruce, “In vivo and in vitro interaction of DnaK and a chloroplast transit peptide,” Cell Stress and Chaperones, vol. 5, no. 1, pp. 62–71, 2000. View at Google Scholar · View at Scopus
  85. R. A. Ivey III, C. Subramanian, and B. D. Bruce, “Identification of a Hsp70 recognition domain within the Rubisco small subunit transit peptide,” Plant Physiology, vol. 122, no. 4, pp. 1289–1299, 2000. View at Google Scholar · View at Scopus
  86. J. Wiesner, A. Reichenberg, S. Heinrich, M. Schlitzer, and H. Jomaa, “The plastid-like organelle of apicomplexan parasites as drug target,” Current Pharmaceutical Design, vol. 14, no. 9, pp. 855–871, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Sousa, A. Pozniak, and M. Boffito, “Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs,” Journal of Antimicrobial Chemotherapy, vol. 62, no. 5, pp. 872–878, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. S. A. Ralph, G. G. van Dooren, R. F. Waller et al., “Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast,” Nature Reviews Microbiology, vol. 2, no. 3, pp. 203–216, 2004. View at Publisher · View at Google Scholar
  89. A. S. Couto, E. A. Kimura, V. J. Peres, M. L. Uhrig, and A. M. Katzin, “Active isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units,” Biochemical Journal, vol. 341, part 3, pp. 629–637, 1999. View at Publisher · View at Google Scholar · View at Scopus
  90. J. G. Geist, S. Lauw, V. Illarionova et al., “Thiazolopyrimidine inhibitors of 2-methylerythritol 2,4-cyclodiphosphate synthase (IspF) from Mycobacterium tuberculosis and Plasmodium falciparum,” ChemMedChem, vol. 5, no. 7, pp. 1092–1101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. C. Y. He, B. Striepen, C. H. Pletcher, J. M. Murray, and D. S. Roos, “Targeting and processing of nuclear-encoded apicoplast proteins in plastid segregation mutants of Toxoplasma gondii,” Journal of Biological Chemistry, vol. 276, no. 30, pp. 28436–28442, 2001. View at Publisher · View at Google Scholar · View at Scopus
  92. T. Kobayashi, S. Sato, S. Takamiya et al., “Mitochondria and apicoplast of Plasmodium falciparum: behaviour on subcellular fractionation and the implication,” Mitochondrion, vol. 7, no. 1-2, pp. 125–132, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. M. K. Moe, P. J. Samuelsen, H. V. Nielsen, and K. M. Nielsen, “Separation of DNA-containing organelles from Toxoplasma gondii by CZE,” Electrophoresis, vol. 31, no. 8, pp. 1344–1349, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. A. R. Odom and W. C. van Voorhis, “Functional genetic analysis of the Plasmodium falciparum deoxyxylulose 5-phosphate reductoisomerase gene,” Molecular and Biochemical Parasitology, vol. 170, no. 2, pp. 108–111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. S. Dalal and M. Klemba, “Roles for two aminopeptidases in vacuolar hemoglobin catabolism in Plasmodium falciparum,” Journal of Biological Chemistry, vol. 282, no. 49, pp. 35978–35987, 2007. View at Publisher · View at Google Scholar · View at Scopus
  96. D. Ragheb, K. Bompiani, S. Dalal, and M. Klemba, “Evidence for catalytic roles for Plasmodium falciparum aminopeptidase P in the food vacuole and cytosol,” Journal of Biological Chemistry, vol. 284, no. 37, pp. 24806–24815, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. D. Ragheb, S. Dalal, K. M. Bompiani, W. K. Ray, and M. Klemba, “Distribution and biochemical properties of an M1-family aminopeptidase in Plasmodium falciparum indicate a role in vacuolar hemoglobin catabolism,” Journal of Biological Chemistry, vol. 286, no. 31, pp. 27255–27265, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. I. Y. Gluzman, S. E. Francis, A. Oksman, C. E. Smith, K. L. Duffin, and D. E. Goldberg, “Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway,” Journal of Clinical Investigation, vol. 93, no. 4, pp. 1602–1608, 1994. View at Google Scholar · View at Scopus
  99. R. Banerjee, J. Liu, W. Beatty, L. Pelosof, M. Klemba, and D. E. Goldberg, “Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 2, pp. 990–995, 2002. View at Publisher · View at Google Scholar · View at Scopus
  100. D. M. Wyatt and C. Berry, “Activity and inhibition of plasmepsin IV, a new aspartic proteinase from the malaria parasite, Plasmodium falciparum,” FEBS Letters, vol. 513, no. 2-3, pp. 159–162, 2002. View at Publisher · View at Google Scholar · View at Scopus
  101. B. R. Shenai, P. S. Sijwali, A. Singh, and P. J. Rosenthal, “Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum,” Journal of Biological Chemistry, vol. 275, no. 37, pp. 29000–29010, 2000. View at Google Scholar · View at Scopus
  102. P. S. Sijwali, L. S. Brinen, and P. J. Rosenthal, “Systematic optimization of expression and refolding of the Plasmodium falciparum cysteine protease falcipain-2,” Protein Expression and Purification, vol. 22, no. 1, pp. 128–134, 2001. View at Publisher · View at Google Scholar · View at Scopus
  103. K. K. Eggleson, K. L. Duffin, and D. E. Goldberg, “Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum,” Journal of Biological Chemistry, vol. 274, no. 45, pp. 32411–32417, 1999. View at Publisher · View at Google Scholar · View at Scopus
  104. K. A. Kolakovich, I. Y. Gluzman, K. L. Duffin, and D. E. Goldberg, “Generation of hemoglobin peptides in the acidic digestive vacuole of Plasmodium falciparum implicates peptide transport in amino acid production,” Molecular and Biochemical Parasitology, vol. 87, no. 2, pp. 123–135, 1997. View at Publisher · View at Google Scholar · View at Scopus
  105. M. Shea, U. Jäkle, Q. Liu, C. Berry, K. A. Joiner, and D. Soldati-Favre, “A family of aspartic proteases and a novel, dynamic and cell-cycle-dependent protease localization in the secretory pathway of Toxoplasma gondii,” Traffic, vol. 8, no. 8, pp. 1018–1034, 2007. View at Publisher · View at Google Scholar · View at Scopus
  106. T. S. Skinner-Adams, C. M. Stack, K. R. Trenholme et al., “Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials,” Trends in Biochemical Sciences, vol. 35, no. 1, pp. 53–61, 2010. View at Publisher · View at Google Scholar · View at Scopus
  107. J. Ziegler, R. Linck, and D. W. Wright, “Heme aggregation inhibitors: antimalarial drugs targeting an essential biomineralization process,” Current Medicinal Chemistry, vol. 8, no. 2, pp. 171–189, 2001. View at Google Scholar · View at Scopus
  108. J. Liu, I. Y. Gluzman, M. E. Drew, and D. E. Goldberg, “The role of Plasmodium falciparum food vacuole plasmepsins,” Journal of Biological Chemistry, vol. 280, no. 2, pp. 1432–1437, 2005. View at Publisher · View at Google Scholar · View at Scopus
  109. J. A. Bonilla, T. D. Bonilla, C. A. Yowell, H. Fujioka, and J. B. Dame, “Critical roles for the digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function,” Molecular Microbiology, vol. 65, no. 1, pp. 64–75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  110. P. A. Moura, J. B. Dame, and D. A. Fidock, “Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 12, pp. 4968–4978, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. A. J. K. Ruben, A. J. K. Y, and E. Freire, “The plasmepsin family as antimalarial drug targets,” in Aspartic Acid Proteases as Therapeutic Targets, A. K. E. Ghosh, Ed., pp. 513–547, WILEY-VCH, Weinheim, Germany, 2010. View at Google Scholar
  112. L. A. Gil, P. A. Valiente, P. G. Pascutti, and T. Pons, “Computational perspectives into plasmepsins structure-function relationship: implications to inhibitors design,” Journal of Tropical Medicine, vol. 2011, Article ID 657483, 15 pages, 2011. View at Publisher · View at Google Scholar
  113. W. Ahmed, M. Rani, I. A. Khan et al., “Characterisation of hydrazides and hydrazine derivatives as novel aspartic protease inhibitors,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 25, no. 5, pp. 673–678, 2010. View at Publisher · View at Google Scholar · View at Scopus
  114. P. B. McKay, M. B. Peters, G. Carta et al., “Identification of plasmepsin inhibitors as selective anti-malarial agents using ligand based drug design,” Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 11, pp. 3335–3341, 2011. View at Publisher · View at Google Scholar · View at Scopus
  115. V. Kasam, M. Zimmermann, A. Maaß et al., “Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid,” Journal of Chemical Information and Modeling, vol. 47, no. 5, pp. 1818–1828, 2007. View at Publisher · View at Google Scholar · View at Scopus
  116. G. Degliesposti, V. Kasam, A. da Costa et al., “Design and discovery of plasmepsin II inhibitors using an automated workflow on large-scale grids,” ChemMedChem, vol. 4, no. 7, pp. 1164–1173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. R. Friedman and A. Caflisch, “Discovery of plasmepsin inhibitors by fragment-based docking and consensus scoring,” ChemMedChem, vol. 4, no. 8, pp. 1317–1326, 2009. View at Publisher · View at Google Scholar · View at Scopus
  118. X. Z. Su, V. M. Heatwole, S. P. Wertheimer et al., “The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes,” Cell, vol. 82, no. 1, pp. 89–100, 1995. View at Google Scholar · View at Scopus
  119. L. Guruprasad, K. Tanneeru, and K. Guruprasad, “Structural rationale for the Recognition of Arginine at P3 in PEXEL motif containing proteins of Plasmodium falciparum by plasmepsin V,” Protein and Peptide Letters, vol. 18, no. 6, pp. 634–641, 2011. View at Google Scholar · View at Scopus
  120. I. Russo, S. Babbitt, V. Muralidharan, T. Butler, A. Oksman, and D. E. Goldberg, “Plasmepsin V licenses Plasmodium proteins for export into the host erythrocyte,” Nature, vol. 463, no. 7281, pp. 632–636, 2010. View at Publisher · View at Google Scholar · View at Scopus
  121. S. Kulzer, S. Charnaud, T. Dagan et al., “Plasmodium falciparum-encoded exported hsp70/hsp40 chaperone/co-chaperone complexes within the host erythrocyte,” Cellular Microbiology, vol. 14, no. 11, pp. 1784–1795, 2012. View at Publisher · View at Google Scholar
  122. H. H. Kampinga and E. A. Craig, “The HSP70 chaperone machinery: J proteins as drivers of functional specificity,” Nature Reviews Molecular Cell Biology, vol. 11, no. 8, pp. 579–592, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. R. S. Hegde and R. J. Keenan, “Tail-anchored membrane protein insertion into the endoplasmic reticulum,” Nature Reviews Molecular Cell Biology, vol. 12, no. 12, pp. 787–798, 2011. View at Publisher · View at Google Scholar
  124. E. Knuepfer, M. Rug, N. Klonis, L. Tilley, and A. F. Cowman, “Trafficking of the major virulence factor to the surface of transfected P falciparum-infected erythrocytes,” Blood, vol. 105, no. 10, pp. 4078–4087, 2005. View at Publisher · View at Google Scholar · View at Scopus
  125. E. Yeh and J. L. DeRisi, “Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum,” PLoS Biology, vol. 9, no. 8, Article ID e1001138, 2011. View at Google Scholar